Clinically Correlated MicroRNAs in the Diagnosis of Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Open Access
- 28 June 2018
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-14
Abstract
(1) Background. Non-small cell lung cancer (NSCLC) has a high mortality rate. MiRNAs have been found to be diagnostic biomarkers for NSCLC. However, controversial results exist. We conducted this meta-analysis to evaluate the diagnostic value of miRNAs for NSCLC.(2) Methods. Databases and reference lists were searched. Pooled sensitivity (SEN), specificity (SPE), and area under the curve (AUC) were applied to examine the general diagnostic efficacy, and subgroup analysis was also performed.(3) Results. Pooled SEN, SPE, and AUC were 85%, 88%, and 0.93, respectively, for 71 studies. Multiple miRNAs (AUC: 0.96) obtained higher diagnostic value than single miRNA (AUC: 0.86), and the same result was found for Caucasian population (AUC: 0.97) when compared with Asian (AUC: 0.91) and Caucasian/African population (AUC: 0.92). MiRNA had higher diagnostic efficacy when participants contained both smokers and nonsmokers (AUC is 0.95 for imbalanced group and 0.91 for balanced group) than when containing only smokers (AUC: 0.90). Meanwhile, AUC was 0.91 for both miR-21 and miR-210.(4) Conclusions. Multiple miRNAs such as miR-21 and miR-210 could be used as diagnostic tools for NSCLC, especially for the Caucasian and nonsmoking NSCLC.Keywords
Funding Information
- National Natural Science Foundation of China (81502878, 201601117)
- Doctoral Research Project of Liaoning Province (81502878, 201601117)
This publication has 66 references indexed in Scilit:
- RETRACTED ARTICLE: Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancerWorld Journal of Surgical Oncology, 2016
- Identification of a three-miRNA signature as a blood-borne diagnostic marker for early diagnosis of lung adenocarcinomaOncotarget, 2016
- Serum miR-499 as a novel diagnostic and prognostic biomarker in non-small cell lung cancerOncology Reports, 2014
- Digital PCR quantification of miRNAs in sputum for diagnosis of lung cancerJournal of Cancer Research and Clinical Oncology, 2013
- microRNAs Derived from Circulating Exosomes as Noninvasive Biomarkers for Screening and Diagnosing Lung CancerJournal of Thoracic Oncology, 2013
- Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLCInternational Journal of Molecular Sciences, 2013
- Quantification of Plasma miRNAs by Digital PCR for Cancer DiagnosisBiomarker Insights, 2013
- Sputum MicroRNA Profiling: A Novel Approach for the Early Detection of Non-Small Cell Lung CancerClinical & Investigative Medicine, 2012
- Reduction of plasma MicroRNA-21 is associated with chemotherapeutic response in patients with non-small cell lung cancerChinese Journal of Cancer Research, 2011
- miRNAs in lung cancer - Studying complex fingerprints in patient's blood cells by microarray experimentsBMC Cancer, 2009